-
mCRPC: Insights on Lu-PSMA, PARP inhibitors, and new targeted approaches
November 5, 2023The second half of Plenary Session 13 “New standards and novel approaches in advanced prostate cancer” was spearheaded by...
0 -
Synergy of specialties at EMUC23: Why MDTs are paramount to optimal patient care
June 7, 2023Throughout the years, the European Multidisciplinary Congress on Urological Cancers (EMUC) has garnered a loyal following and a steady growth...
